I. Nakamura

发表

HLA B44–restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein

Y. Yazaki, H. Kita, M. Nomura, 1993, Hepatology.

Molecular biology of hepatitis B virus and hepatocellular carcinoma

K. Koike, S. Takada, Midori Kobayashi, 1992 .

Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: Increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection

B. Tennant, J. Gerin, P. Cote, 2000, Hepatology.

Hepatitis B core antigen stimulates interleukin‐10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection

M. Imawari, I. Nakamura, N. Hyodo, 2004, Clinical and experimental immunology.

Interferon β-responsive inclusion body myositis in a hepatitis C virus carrier

J. Satoh, I. Nishino, K. Yamaguchi, 2004, Neurology.

Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein.

H. Kita, M. Imawari, K. Hiroishi, 1996, The Journal of general virology.

Recognition of Hepatitis C Virus Nucleocapsid Protein-derived Peptides by Cytotoxic T Lymphocytes

Y. Yazaki, H. Kita, M. Nomura, 1994 .

A transcription initiation site for the hepatitis B virus X gene is directed by the promoter-binding protein

K. Koike, S. Takada, I. Nakamura, 1993, Journal of virology.

Contribution of HBV X Gene Expression to Hepatic Carcinogenesis

K. Koike, N. Tsuchida, H. Kido, 1994 .

Adoptive immunotherapy of primary and metastatic liver cancer via hepatic artery catheter.

H. Nakagama, N. Matsuhashi, F. Takaku, 1990, European journal of cancer.

Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus.

H. Nakagama, K. Oshimi, S. Ohnishi, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: Chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor‐alpha messenger RNAs

B. Tennant, J. Casey, J. Gerin, 2001, Hepatology.

Oncogenic potential of hepatitis B virus.

K. Koike, S. Takada, Midori Kobayashi, 1989, Molecular biology & medicine.

Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3ϵ with applications for the detection of RNA expression in tissues by RT‐PCR assay

J. Casey, J. Gerin, P. Cote, 1997 .

Identification of a binding protein to the X gene promoter region of hepatitis B virus.

K. Koike, I. Nakamura, 1992, Virology.

Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins

M. Al-Ahdal, T. D. Flanagan, I. Nakamura, 1985, Journal of virology.

Oncogenic potential of hepatitis B virus.

K. Koike, S. Takada, Y. Hayashi, 1989, Molecular biology & medicine.

Interferon beta-responsive inclusion body myositis in a hepatitis C virus carrier.

J. Satoh, I. Nishino, K. Yamaguchi, 2004, Neurology.

HLA B44–restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein

H. Kita, M. Imawari, T. Moriyama, 1993, Hepatology.